FDA clears I-STAT's prothrombin time test:
This article was originally published in Clinica
Executive Summary
i-STAT has gained US FDA 510(k) clearance to market its prothrombin time test for monitoring patients who are receiving anti-coagulant therapy to prevent blood clot formation. The test is designed for use on the East Windsor, New Jersey firm's point-of-care i-STAT analyser.